11/27/24 16:08 | 11/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 858 | D | | | | | | | | | | | | | | |
9/12/24 18:13 | 8/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 833 | D | | | | | | | | | | | | | | |
5/29/24 19:07 | 5/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 808 | D | | | | | | | | | | | | | | |
2/27/24 19:58 | 2/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 783 | D | | | | | | | | | | | | | | |
11/28/23 19:03 | 11/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 757 | D | | | | | | | | | | | | | | |
8/29/23 18:52 | 8/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 732 | D | | | | | | | | | | | | | | |
5/26/23 19:32 | 5/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 707 | D | | | | | | | | | | | | | | |
2/28/23 18:30 | 2/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 682 | D | | | | | | | | | | | | | | |
11/29/22 17:18 | 11/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 657 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 631 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -54 | 4.01 | 0 | -13 | -2 | 631 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -25 | 1.90 | 0 | -13 | -2 | 620 | D | | | | | | | | | | | | | | |